
Aka gatabo karambuye kerekana iterambere rigezweho muri kuvura kanseri y'ibihaha, gutanga ubushishozi muburyo butandukanye bwo kuvura, ingaruka zabyo, n'ingaruka zishobora kubaho. Twinjiye mubuvuzi bwashyizweho kandi bugenda bugaragara kugirango tugufashe kumva amahitamo aboneka no gufata ibyemezo byuzuye mubyumvikanyeho nabashinzwe ubuzima. Kugenda bigoye bya kuvura kanseri y'ibihaha bisaba kumva neza indwara nubuvuzi buhari. Iyi ngingo igamije gutanga ibyo bisobanutse.
Gutegura neza kanseri y'ibihaha yateye imbere ni ngombwa mu kumenya inzira nziza yo kuvura. Ibi birimo urukurikirane rwibizamini, birimo amashusho yerekana amashusho (CT, PET), biopsies, hamwe no gupima amaraso. Icyiciro cya kanseri - cyaba cyateye imbere cyangwa metastatike - bigira ingaruka zikomeye kumahitamo yo kuvura. Gusobanukirwa umwihariko w'isuzuma ryawe nintambwe yambere mugutegura gahunda yo kuvura yihariye.
Kanseri y'ibihaha yateye imbere ikubiyemo kanseri ntoya y'ibihaha (SCLC) na kanseri y'ibihaha itari ntoya (NSCLC). NSCLC ifite umubare munini w'abantu banduye kanseri y'ibihaha kandi irashyirwa mu byiciro (adenocarcinoma, kanseri y'udukoko twa kanseri, kanseri nini ya kanseri), buri wese ashobora kwitabira mu buvuzi butandukanye. Iri tandukaniro ni ingenzi mu kudoda kwivuza ingamba.
Chimoterapi ikomeza kuba umusingi wa kuvura kanseri y'ibihaha. Harimo gukoresha ibiyobyabwenge kugirango wice kanseri, akenshi bikoreshwa mu mitsi. Uburyo bwinshi bwa chimiotherapie burahari, buri kimwe kijyanye n'ubwoko bwihariye bwa kanseri. Guhitamo gahunda byerekana ibintu nkubuzima bwumurwayi muri rusange no kuba hari ihinduka ry’imiterere yihariye. Imiti ikoreshwa cyane ya chimiotherapeutique irimo cisplatine, karboplatine, na paclitaxel. Ingaruka zinyuranye ziratandukanye ariko zirashobora kubamo isesemi, umunaniro, no guta umusatsi.
Ubuvuzi bugamije kwibanda kuri molekile yihariye itera kanseri. Ubu buryo bwo kuvura bugira akamaro cyane cyane ku barwayi bafite ihindagurika ry’imiterere, nka EGFR, ALK, ROS1, cyangwa ihinduka rya BRAF. Ingero zirimo EGFR tyrosine kinase inhibitor (TKIs) nka gefitinib na erlotinib, hamwe na ALK inhibitor nka crizotinib. Imikorere yubuvuzi bugamije guterwa no kuba hari ibimenyetso byihariye byerekanwe hakoreshejwe ibizamini bya biopsy. Shandong Baofa Ikigo Cyubushakashatsi Kanseri itanga ibizamini bya genetike bigezweho kugirango bayobore ibyemezo byo kuvura byihariye.
Immunotherapy ikoresha imbaraga z'umubiri zo kurwanya kanseri. Immune igenzura, nka pembrolizumab na nivolumab, ihagarika poroteyine zibuza umubiri kwirinda indwara ya kanseri. Ibi biyobyabwenge byahinduye Uwiteka kwivuza ya bamwe kanseri yateye imbere, biganisha ku iterambere ryinshi mubipimo byo kubaho. Nyamara, immunotherapy ntabwo ikora neza kubarwayi bose, kandi ingaruka zirashobora kuba zirimo umunaniro nibintu bibi biterwa nubudahangarwa.
Imiti ivura imirasire ikoresha imirasire yingufu nyinshi kugirango yice selile. Irashobora gukoreshwa mukugabanya ibibyimba, kugabanya ibimenyetso, cyangwa kunoza imikorere yubuvuzi. Ubuvuzi bwa stereotactique yumubiri (SBRT) nuburyo bwuzuye bwimirasire itanga urugero rwinshi rwimirasire mukarere gato, bikagabanya kwangirika kwinyama nzima. Imiti ivura imirasire irashobora gutera ingaruka nko kurakara kuruhu n'umunaniro.
Kubaga birashobora kuba amahitamo kubarwayi bamwe na bamwe bateye imbere kanseri y'ibihaha, cyane cyane niba ikibyimba kidashoboka (gishobora gukurwaho kubagwa). Uburyo bwo kubaga buterwa nubunini bwikibyimba nubuzima bwumurwayi muri rusange. Tekinike yo kubaga byibuze irashobora guhitamo kugabanya igihe cyo gukira nibibazo.
Guhitamo icyiza kuvura kanseri y'ibihaha bisaba gutekereza cyane kubintu byinshi, harimo icyiciro nubwoko bwa kanseri, ubuzima bwumurwayi muri rusange, ningaruka zishobora guterwa. Itsinda ry’ibice byinshi by’inzobere mu buvuzi, harimo n’abaganga ba oncologue, abaganga babaga, n’abavuzi ba oncologiste, bagomba gufatanya gutegura gahunda yo kuvura yihariye ijyanye n’ibyo umurwayi akeneye. Gushyikirana kumugaragaro nitsinda ryanyu ryubuzima ni ngombwa muri kwivuza inzira.
Inshingano: Aya makuru agenewe intego zuburezi gusa kandi ntagomba gufatwa nkinama zubuvuzi. Buri gihe ujye ubaza inzobere mu by'ubuzima zujuje ibisabwa kugira ngo zisuzume kandi zivure indwara iyo ari yo yose.
Inkomoko: [Andika amasoko yizewe kubarurishamibare namakuru yatanzwe mu ngingo. Shyiramo imiyoboro ihuza imbuga n’imiryango izwi nka Ikigo cy’igihugu gishinzwe kanseri (NCI) cyangwa Ishyirahamwe ry’ibihaha muri Amerika (ALA).]